Lumosa Therapeutics, a public traded company i
Industries BiotechnologyHeadquarters Regions Asia-Pacific (APAC) Founded Date 2001 Operating Status Active Legal Name Lumosa Therapeutics Co. Ltd.
Company Type For Profit
Lumosa Therapeutics, a public traded company in Taipei Exchange (6535.TWO), is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases of unmet medical needs. The company is actively engaged in scientific in-licensing and new drug development under the “reSEARCH and DEVELOPMENT” model. This
model is executed by a highly capable and experienced cross-functional teams of translational research, CMC, preclinical, clinical development, project management, regulatory affairs, intellectual property and business development experts.